NCT04043702View on ClinicalTrials.gov

Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

July 20, 2019

Study Completion Date

July 29, 2019

Conditions
Obesity
Interventions
DRUG

The intervention being studied

Intervention Other Names have not been specified

Trial Locations (1)

11759

Mahmoud Younis, Cairo

All Listed Sponsors
lead

Ministry of Health and Population, Egypt

OTHER_GOV

NCT04043702 - Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity | Biotech Hunter | Biotech Hunter